TAE Life Sciences
Biotechnology, Health Care, Hospital, Life Science
Founded in 1/1/17
Foothill Ranch, California, United States
For Profit
About TAE Life Sciences
TAE Life Sciences is developing a novel biological-targeting radiation therapy based on Boron Neutron Capture Therapy (BNCT) to improve the lives of patients with rapidly spreading, invasive and recurrent cancers that do not respond to other cancer therapies. TLS is the only company with a comprehensive target drug and neutron technology product portfolio to enable next-generation combination cancer therapy as a first-line treatment for patients globally.
Company Metrics
- Employees: 10-Jan
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 70000000 USD
- Last Funding: 30000000 USD (Series B)
- Funding Status: Early Stage Venture
Technology Stack
TAE Life Sciences actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Hospital, Life Science
Headquarters: Foothill Ranch, California, United States